151 related articles for article (PubMed ID: 29391198)
1. A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides.
Mashima E; Sawada Y; Yamaguchi T; Yoshioka H; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
Clin Immunol; 2018 Aug; 193():121-122. PubMed ID: 29391198
[No Abstract] [Full Text] [Related]
2. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.
van Doorn R; Van Haselen CW; van Voorst Vader PC; Geerts ML; Heule F; de Rie M; Steijlen PM; Dekker SK; van Vloten WA; Willemze R
Arch Dermatol; 2000 Apr; 136(4):504-10. PubMed ID: 10768649
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
5. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac involvement in mycosis fungoides].
Fritz GA; Mohadjer D; Schaffler G; Reittner P
Rofo; 2006 Sep; 178(9):918-9. PubMed ID: 16894505
[No Abstract] [Full Text] [Related]
7. Mycosis fungoides: clinical features and management.
Blaylock WK
Prog Clin Biol Res; 1978; 25():149-56. PubMed ID: 310557
[No Abstract] [Full Text] [Related]
8. Manifestations of cutaneous T-cell lymphoma.
Carney DN; Bunn PA
J Dermatol Surg Oncol; 1980 May; 6(5):369-77. PubMed ID: 6966639
[No Abstract] [Full Text] [Related]
9. CADM1: A molecule worth investigating in mycosis fungoides and Sézary syndrome.
Zhang S; Wang T; Liu Y
J Am Acad Dermatol; 2020 Apr; 82(4):e141-e142. PubMed ID: 31857109
[No Abstract] [Full Text] [Related]
10. Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
Neinaa YME; El-Maadawy IH; Atteia IA; Mohamed DAE
Arch Dermatol Res; 2023 Oct; 315(8):2403-2411. PubMed ID: 36943432
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on cutaneous T cell lymphoma.
Clendenning WE
Clin Exp Dermatol; 1986 Mar; 11(2):109-26. PubMed ID: 3013469
[No Abstract] [Full Text] [Related]
12. The Impact of Primary Tumor Site on Survival in Mycosis Fungoides.
Go CC; Zhong A; Linaburg T; Briceño CA
Cutis; 2024 Apr; 113(4):177-182. PubMed ID: 38820109
[TBL] [Abstract][Full Text] [Related]
13. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.
Novelli S; García-Muret P; Mozos A; Sierra J; Briones J
Leuk Lymphoma; 2016 May; 57(5):1060-6. PubMed ID: 27096891
[TBL] [Abstract][Full Text] [Related]
14. Papular mycosis fungoides on the legs: a case report.
Santamarina-Albertos A; Muñoz-Martínez R; Alvarez-Gago T; Miranda-Romero A
Actas Dermosifiliogr; 2014; 105(1):87-9. PubMed ID: 23339994
[No Abstract] [Full Text] [Related]
15. Mycosis fungoides.
Vázquez Botet M; Sánchez JL
Bol Asoc Med P R; 1980 Apr; 72(4):188-91. PubMed ID: 6930976
[No Abstract] [Full Text] [Related]
16. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.
Benner MF; Jansen PM; Vermeer MH; Willemze R
Blood; 2012 Feb; 119(7):1643-9. PubMed ID: 22160616
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides.
Gleason L; Cohen A; South AP; Porcu P; Nikbakht N
JAMA Dermatol; 2023 Aug; 159(8):888-890. PubMed ID: 37285150
[TBL] [Abstract][Full Text] [Related]
18. Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.
Danish HH; Liu S; Jhaveri J; Flowers CR; Lechowicz MJ; Esiashvili N; Khan MK
Leuk Lymphoma; 2016 Dec; 57(12):2813-2819. PubMed ID: 27104864
[TBL] [Abstract][Full Text] [Related]
19. Vesicular mycosis fungoides.
Gantcheva M; Lalova A; Broshtilova V; Negenzova Z; Tsankov N
J Dtsch Dermatol Ges; 2005 Nov; 3(11):898-900. PubMed ID: 16232278
[TBL] [Abstract][Full Text] [Related]
20. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
